Cardio-Oncology
AHA guidance identifies potential drug-to-drug interactions between CV, cancer medications
In a recent American Heart Association scientific statement, a committee provided an overview of drug-to-drug interactions between cancer drugs and commonly used CV medications.
New cancer diagnosis associated with risk for fatal, nonfatal cardiovascular events
New cancer diagnosis appeared associated with increased risk for cardiovascular death, as well as incident heart failure, stroke or pulmonary embolism, according to a retrospective cohort study published in JACC: CardioOncology.
Radiotherapy may confer poor long-term CV survival in patients with certain cancers
Among individuals with certain cancers, treatment with radiotherapy was associated with poorer long-term CV-specific survival compared with those who did not undergo radiotherapy, researchers reported.
Chronic high-dose angiotensin receptor blocker use associated with cancer risk
Cumulative exposure to high-dose angiotensin receptor blockers was associated with excess risk for cancer, according to a meta-regression analysis published in PLOS One.
Chemotherapy-induced agranulocytosis plus AF tied to poor clinical outcomes
Concomitant chemotherapy-induced agranulocytosis and atrial fibrillation was associated with increased in-hospital mortality, hospital stay and health care cost among patients with cancer, a speaker reported.
Speaker: Cardio-oncology patients report satisfaction with telehealth amid pandemic
Researchers reported high patient satisfaction with cardio-oncology telehealth consultations during the COVID-19 pandemic.
HF may be tied to cancer incidence, mortality in those 50 years and older
HF may be associated with cancer incidence as well as risk for cancer-related mortality, especially among individuals aged 50 to 70 years, according to new data published in JACC: CardioOncology.
Myocarditis from immune checkpoint inhibitors linked with life-threatening arrhythmias
According to a new study, immune checkpoint inhibitor-induced myocarditis is highly associated with arrhythmias and ECG findings including new conduction blocks, decreased voltage and repolarization abnormalities.
Incidence of cardiac amyloidosis on the rise, mortality improving
The incidence of cardiac amyloidosis in the Danish population increased in the last 2 decades, translating to a potential increase in the global population, according to research published in JACC: CardioOncology.
Tafamidis stabilizes transthyretin in cohort with transthyretin amyloid cardiomyopathy
According to a non-trial, published in JACC: CardioOncology, in unselected patients, serum transthyretin change after tafamidis initiation for transthyretin amyloid cardiomyopathy may serve as a surrogate measure of drug efficacy.